In vitro and in vivo analysis of pro-and anti-inflammatory effects of weak and strong contact allergens

Experimental Dermatology

Volumn 19, Issue 11, 2010, Pages 1007-1013

  Lass, Christian ^a,b   Merfort, Irmgard ^b   Martin, Stefan F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Arnica; Contact dermatitis; Inflammation; Sesquiterpene lactone

Indexed keywords

CONTACT ALLERGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PICRYL CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ALLERGENS; ANIMALS; ARNICA; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EAR, EXTERNAL; FEMALE; GENE EXPRESSION; IMMUNIZATION; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLANT EXTRACTS; RECEPTORS, ANTIGEN, T-CELL; SKIN; TRINITROBENZENES;

EID: 77958586769     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01136.x     Document Type: Article

References (48)

1. Martin S F. T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int Arch Allergy Immunol 2004: 134: 186-198.
2. Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas J F. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009: 64: 1699-1714.
3. Martin S F, Merfort I, Thierse H J. Interactions of chemicals and metal ions with proteins and role for immune responses. Mini Rev Med Chem 2006: 6: 247-255.
4. Freudenberg M A, Esser P R, Jakob T, Galanos C, Martin S F. Innate and adaptive immune responses in contact dermatitis: analogy with infections. G Ital Dermatol Venereol 2009: 144: 173-185.
5. Kerstan A, Leverkus M, Trautmann A. Effector pathways during eczematous dermatitis: where inflammation meets cell death. Exp Dermatol 2009: 18: 893-899.
6. Dudda J C, Simon J C, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004: 172: 857-863.
7. Dudda J C, Lembo A, Bachtanian E et al. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur J Immunol 2005: 35: 1056-1065.
8. Dearman R J, Kimber I. Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology 2000: 101: 442-451.
9. Vandebriel R J, De Jong W H, Spiekstra S W et al. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol Appl Pharmacol 2000: 162: 77-85.
10. Hayashi M, Higashi K, Kato H, Kaneko H. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c. Toxicol Appl Pharmacol 2001: 177: 38-45.
11. Ulrich P, Grenet O, Bluemel J et al. Cytokine expression profiles during murine contact allergy: T helper 2 cytokines are expressed irrespective of the type of contact allergen. Arch Toxicol 2001: 75: 470-479.
12. Van Och F M, Van Loveren H, De Jong W H, Vandebriel R J. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol Appl Pharmacol 2002: 184: 46-56.
13. Dearman R J, Betts C J, Caddick H T, Flanagan B F, Kimber I. Cytokine profiling of chemical allergens in mice: measurement of message versus protein. Toxicology 2008: 252: 17-25.
14. Dearman R J, Betts C J, Humphreys N et al. Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol Sci 2003: 71: 137-145.
15. Martin S F, Dudda J C, Bachtanian E et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med 2008: 205: 2151-2162.
16. Enk A H, Angeloni V L, Udey M C, Katz S I. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 1993: 150: 3698-3704.
17. Kermani F, Flint M S, Hotchkiss S A. Induction and localization of cutaneous interleukin-1 beta mRNA during contact sensitization. Toxicol Appl Pharmacol 2000: 169: 231-237.
18. Cumberbatch M, Dearman R J, Kimber I. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 1997: 92: 388-395.
19. Boonstra A, Asselin-Paturel C, Gilliet M et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003: 197: 101-109.
20. Askenase P W, Itakura A, Leite-de-Moraes M C et al. TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+NKT cells to initiate contact sensitivity in vivo. J Immunol 2005: 175: 6390-6401.
21. Campos R A, Szczepanik M, Itakura A et al. Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology 2006: 117: 536-547.
22. Martin S F, Jakob T. From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008: 8: 289-293.
23. Cavani A. T regulatory cells in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008: 8: 294-298.
24. Grimbaldeston M A, Nakae S, Kalesnikoff J, Tsai M, Galli S J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007: 8: 1095-1104.
25. Yanaba K, Bouaziz J D, Haas K M, Poe J C, Fujimoto M, Tedder T F. A regulatory B cell subset with a unique CD1dhiCD5+phenotype controls T cell-dependent inflammatory responses. Immunity 2008: 28: 639-650.
26. Enk A H, Angeloni V L, Udey M C, Katz S I. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993: 151: 2390-2398.
27. Lass C, Vocanson M, Wagner S et al. Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L. Exp Dermatol 2008: 17: 849-857.
28. Kammeyer A, Bos J D, Teunissen M B M. Postelicitation model of allergic contact dermatitis for predicting the efficacy of topical drugs. Exp Dermatol 2009: 18: 44-49.
29. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel R M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989: 342: 559-561.
30. Wagner S, Merfort I. Skin penetration behaviour of sesquiterpene lactones from different Arnica preparations using a validated GC-MSD method. J Pharm Biomed Anal 2007: 43: 32-38.
31. Willuhn G, Rottger P M, Matthiesen U. Helenalin-and 11, 13-Dihydrohelenalinester from Flowers of Arnica montana. Planta Med 1983: 49: 226-231.
32. Willuhn G, Leven W. Zur qualitativen und quantitativen Analyse der Sesquiterpenlactone von Arnikablüten DAB 9. Pharm Ztg Wiss 1991: 136: 32-39.
33. Martin S F, Dudda J C, Delattre V et al. Fas-mediated inhibition of CD4+T cell priming results in dominance of type 1 CD8+T cells in the immune response to the contact sensitizer trinitrophenyl. J Immunol 2004: 173: 3178-3185.
34. Kyburz D, Aichele P, Speiser D E, Hengartner H, Zinkernagel R M, Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 1993: 23: 1956-1962.
35. Wagner S, Suter A, Merfort I. Skin penetration studies of Arnica preparations and of their sesquiterpene lactones. Planta Med 2004: 70: 897-903.
36. Watanabe H, Gaide O, Petrilli V et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007: 127: 1956-1963.
37. Sutterwala F S, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006: 24: 317-327.
38. Matsue H, Edelbaum D, Shalhevet D et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003: 171: 3010-3018.
39. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009: 27: 229-265.
40. Antonopoulos C, Cumberbatch M, Mee J B et al. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 2008: 83: 361-367.
41. Cumberbatch M, Dearman R J, Antonopoulos C, Groves R W, Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha-and IL-1beta-dependent mechanism. Immunology 2001: 102: 323-330.
42. Hope J C, Campbell F, Hopkins S J. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response. Eur J Immunol 2000: 30: 197-203.
43. Piguet P F, Grau G E, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991: 173: 673-679.
44. Shornick L P, Bisarya A K, Chaplin D D. IL-1beta is essential for Langerhans cell activation and antigen delivery to the lymph nodes during contact sensitization: evidence for a dermal source of IL-1beta. Cell Immunol 2001: 211: 105-112.
45. Ring S, Schafer S C, Mahnke K, Lehr H A, Enk A H. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 2006: 36: 2981-2992.
46. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003: 299: 1033-1036.
47. Gerberick G F, Ryan C A, Kern P S et al. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 2005: 16: 157-202.
48. Kern P S, Gerberick G F, Ryan C A, Kimber I, Aptula A, Basketter D A. Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis 2010: 21: 8-32.